Hormone therapy can delay prostate cancer spread in people treated with surgery and radiotherapy
People with prostate cancer who have had surgery to remove their prostate, and then received radiotherapy, can benefit from hormone therapy.
Adding abiraterone to standard therapy helps people with metastatic prostate cancer to live longer
Adding the drug abiraterone to standard hormone therapy helps people with prostate cancer that has spread to other parts of the body to live longer.
The REFINE Trial is presented at the European Society for Medical Oncology Congress
Sophie Merrick presented the REFINE trial at the ESMO Congress in Paris on the 12th September
Dolutegravir-based HIV treatment is better for babies and young children
Babies and young children treated with the anti-HIV drug dolutegravir, in combination with other anti-HIV drugs, are more likely to keep the virus under control, compared to those treated with standard anti-HIV treatment…
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Major international clinical trials answering questions of global public health significance
New generation of innovative multi-arm, multi stage platform clinical trials to identify and test new therapeutic treatments in neurodegenerative diseases
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
Congrats to the sites 🟡Queen Alexandra Hospital @PHU_NHS 🔵@CHFTNHS Royal Infirmary 🟠@AiredaleNHSFT for being 🔝 recruiters to the #STAMPEDEtrial Metabolic sub-study, looking at the effect of #metformin on metabolic changes linked to #ADT https://t.co/wNbCNXGjGj
Exciting news to speed up #ProstateCancer diagnosis! A new clinical imaging dataset from the #PROMIStrial is now available to researchers involved in #AI tools for #ProstateCancer. @imaging_cancer @ReIMAGINE_PCa @NIHR_RDS @CRUKresearch @ProstateUKProfs https://t.co/Fl6bZgjUPC